- Home
- PTLO vs BNTC Comparison
PTLO vs BNTC Comparison
Compare PTLO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- BNTC
- Stock Information
- Founded
- PTLO 1963
- BNTC 1995
- Country
- PTLO United States
- BNTC United States
- Employees
- PTLO N/A
- BNTC N/A
- Industry
- PTLO Restaurants
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- PTLO Consumer Discretionary
- BNTC Health Care
- Exchange
- PTLO Nasdaq
- BNTC Nasdaq
- Market Cap
- PTLO 355.3M
- BNTC 365.1M
- IPO Year
- PTLO 2021
- BNTC N/A
- Fundamental
- Price
- PTLO $4.76
- BNTC $13.12
- Analyst Decision
- PTLO Buy
- BNTC Strong Buy
- Analyst Count
- PTLO 9
- BNTC 5
- Target Price
- PTLO $9.89
- BNTC $26.60
- AVG Volume (30 Days)
- PTLO 3.5M
- BNTC 277.3K
- Earning Date
- PTLO 11-04-2025
- BNTC 11-14-2025
- Dividend Yield
- PTLO N/A
- BNTC N/A
- EPS Growth
- PTLO N/A
- BNTC N/A
- EPS
- PTLO 0.35
- BNTC N/A
- Revenue
- PTLO $730,930,000.00
- BNTC N/A
- Revenue This Year
- PTLO $5.70
- BNTC N/A
- Revenue Next Year
- PTLO $8.18
- BNTC N/A
- P/E Ratio
- PTLO $13.57
- BNTC N/A
- Revenue Growth
- PTLO 2.40
- BNTC N/A
- 52 Week Low
- PTLO $4.64
- BNTC $9.10
- 52 Week High
- PTLO $15.78
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- PTLO 33.26
- BNTC 39.88
- Support Level
- PTLO $4.64
- BNTC $11.54
- Resistance Level
- PTLO $4.83
- BNTC $13.89
- Average True Range (ATR)
- PTLO 0.22
- BNTC 1.26
- MACD
- PTLO -0.00
- BNTC -0.32
- Stochastic Oscillator
- PTLO 14.36
- BNTC 32.17
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.